OncoCyte Corporation Profile Avatar - Palmy Investing

OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test fo…

Biotechnology
US, Irvine [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

OncoCyte Corporation can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

OncoCyte Corporation can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of OncoCyte Corporation.

If you want to see a demo, head over to the financial segments of AAPL

End of OCX's Analysis
CIK: 1642380 CUSIP: 68235C107 ISIN: US68235C2061 LEI: - UEI: -
Secondary Listings
OCX has no secondary listings inside our databases.